India's Alembic Pharmaceuticals falls after lower Q4 profit
06/05/2025 09:41
** Shares of Alembic Pharmaceuticals ALEM.NS fall 1.9% to 887.90 rupees ** Pharma co's Q4 consol net profit falls 12% Y/Y to 1.57 bln rupees ($18.6 mln) due to higher tax expenses; revenue up 16.7% Y/Y ** ALEM down ~17% YTD ($1 = 84.3750 Indian rupees) (Reporting by Vijay Malkar) ((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand